• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Greene calls for yanking FDA approval of COVID-19 vaccines: ‘Causing permanent harm and deaths’

by March 21, 2025
written by March 21, 2025

Rep. Marjorie Taylor Greene, R-Ga., declared that U.S. Food and Drug Administration approval for COVID-19 vaccines should be yanked, asserting that the jabs ‘are causing permanent harm and deaths.’

‘FDA approval for COVID-19 vaccines needs to be pulled and they need taken off the childhood vaccine schedule ASAP,’ she said Thursday in a post on X. ‘I’ve been saying this ever since they were created and my personal Twitter account was permanently banned for my outspoken stance against the vaccines until Elon Musk bought Twitter, changed it to X, and restored my account along with thousands of people who were censored and silenced.’

The child and adolescent immunization schedule on the Centers for Disease Control and Prevention website includes COVID-19 vaccine recommendations for children 6 months old and above.

Greene contends that the jabs should never have been approved in the first place.

‘COVID-19 vaccines should have never received approval and they’ve known the entire time how bad the side effects are and deaths caused by them. It’s time to do the right thing. Stop the COVID-19 vaccines,’ she declared in her post.

But the CDC notes, ‘COVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19. There is currently no FDA-approved or FDA-authorized COVID-19 vaccine for children younger than age 6 months. CDC recommends that people stay up to date with COVID-19 vaccination.’

‘Cases of myocarditis and pericarditis have rarely been observed following receipt of COVID-19 vaccines used in the United States,’ the CDC indicates.

‘Evidence from multiple monitoring systems support a causal association for mRNA COVID-19 vaccines (Moderna or Pfizer-BioNTech) and myocarditis and pericarditis. Cases have occurred most frequently in adolescent and young adult males within 7 days after receiving the second dose of an mRNA COVID-19 vaccine (Moderna and Pfizer-BioNTech); however, cases have also been observed in females and after other doses.’

Rep. Thomas Massie has also expressed the view that the FDA should nix approval for the COVID-19 vaccines. 

‘FDA should immediately revoke approval of these shots,’ he tweeted last month.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Bernie Sanders, AOC take aim at Trump and Musk, as well as Democrats, at western rallies
next post
Trump’s hostage envoy Boehler met with Taliban in Kabul in first in-person meeting since takeover

related articles

From Biden’s ‘war’ on gas prices to ‘small...

March 13, 2026

US diplomatic facility in Iraq struck by drone

March 13, 2026

171 million travelers face airport delays as Democrats’...

March 13, 2026

From Biden’s ‘war’ on gas prices to ‘small...

March 13, 2026

FDA launches new AI-powered system to track drug...

March 13, 2026

Cornyn reverses on filibuster stance to push Trump’s...

March 13, 2026

DAVID MARCUS: Sen Thune has no idea how...

March 13, 2026

Trump touts 5-0 sweep by endorsed candidates in...

March 13, 2026

US destroys 16 Iranian mine boats as Strait...

March 13, 2026

House GOP urges Trump to choke off Iran...

March 13, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • State Department stops issuing all visitor visas for individuals from Gaza

    August 16, 2025
  • Trump envoy meets Putin in Russia as Trump fumes over stalled Ukraine peace talks

    April 11, 2025
  • Trump’s tariffs could be undone by one conservative doctrine: ‘Life or death’

    January 16, 2026
  • These are the top names in contention for defense secretary under Trump

    November 12, 2024
  • Multiple outbursts erupt at RFK Jr hearing: ‘You are!’

    January 29, 2025

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    CoreWeave eyes $1.5B bond raise to ease debt load following lacklustre IPO: report

    May 9, 2025

Categories

  • Economy (829)
  • Editor's Pick (8,376)
  • Investing (1,189)
  • Stock (981)

Latest Posts

  • Rubio designates Afghanistan as ‘state sponsor of wrongful detention’: ‘Despicable tactics’

    March 11, 2026
  • Move on Unicredit: Societe Generale stock is firing on all cylinders

    March 6, 2025
  • Darden Restaurants sales disappoint as Olive Garden, LongHorn Steakhouse miss expectations

    March 20, 2025

Recent Posts

  • McCaul says Israel strikes are ‘perfect opportunity’ for Iranians to overthrow Islamic regime

    June 13, 2025
  • Top Trump ally predicts Senate will blow past ‘big, beautiful bill’ deadline

    June 19, 2025
  • Debt-ridden Harris campaign spent $2.6 million on private flights for staff in October: FEC documents

    November 17, 2024

Editor’s Pick

  • Morning brief: Asia stocks rally on US-India trade deal, SpaceX acquires xAI

    February 3, 2026
  • Speaker Johnson announces new Capitol bathroom policy in response to controversy over trans House member

    November 20, 2024
  • Trump says he ‘would be willing to do more than one debate’ with Vice President Harris

    July 23, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock